Francoise Beltjens

Dijon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort.

Age-related distribution of homologous recombination deficiency in advanced ovarian carcinoma: a large real-world French cohort.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 26, 2026

Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 11, 2025

Case #2. Breast mucinous cystadenocarcinoma: A case report

Case #2. Breast mucinous cystadenocarcinoma: A case report

Journal: Annales de pathologie

Published: October 29, 2024

Underestimation of pure radial scars: A retrospective evaluation in a cancer center

Underestimation of pure radial scars: A retrospective evaluation in a cancer center

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: October 15, 2024

Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.

Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.

Journal: Biomedicines

Published: September 30, 2024

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC.

Journal: Frontiers in immunology

Published: May 24, 2024

HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity.

HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity.

Journal: Cancers

Published: May 02, 2024

Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.

Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 29, 2023

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.

Journal: Frontiers in oncology

Published: October 08, 2023

Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.

Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.

Journal: Breast cancer (Tokyo, Japan)

Published: June 10, 2023

Axillary pathologic response after neoadjuvant chemotherapy and surgery according to breast cancers subtypes and survival impact.

Axillary pathologic response after neoadjuvant chemotherapy and surgery according to breast cancers subtypes and survival impact.

Journal: Bulletin du cancer

Published: December 22, 2022

Evaluation of the management of intracystic papillary carcinoma.

Evaluation of the management of intracystic papillary carcinoma.

Journal: Bulletin du cancer

Published: December 05, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026